Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
NEW
Pt(IV)-M13
Item number: TGM-TP3022-10mg
Description: Pt(IV)-M13 is a platinum (IV) prodrug conjugated with a perfluoroaryl macrocyclic peptide, capable of crossing the blood-brain barrier. It exhibits cytotoxicity towards glioblastoma stem cells and enhances platinum uptake in the brain, making it a valuable tool for glioblastoma research. Target: Others
| MW: | 2947.63 D |
Please request pricing for this article.
NEW
R4K1
Item number: TGM-TP3026-10mg
Description: R4K1 is a cell-permeable stapled peptide that binds with high affinity to estrogen receptor (ER) alpha, inhibiting its interaction with coactivators. It penetrates breast cancer cells, regulating gene transcription and suppressing cell proliferation. R4K1 is applicable for tumor research. Target:...
| MW: | 1912.25 D |
Please request pricing for this article.
NEW
Petrelintide acetate
Item number: TGM-TP3039-10mg
Description: Petrelintide (ZP8396) acetate is an amylin analog with potential for weight reduction, suitable for diabetes research. Target: Amylin Receptor
| Keywords: | ZP8396 acetate , Petrelintide acetate |
| MW: | 4191.69 D |
Please request pricing for this article.
NEW
APL180 TFA
Item number: TGM-TP3049-2mg
Description: APL180 TFA (L-4F) is an apolipoprotein A-I mimetic peptide that enhances the anti-inflammatory properties of high-density lipoprotein (HDL). APL180 is applicable for cardiovascular disease research. Target: Others, Apolipoprotein
| Keywords: | APL180 TFA , L-4F TFA |
| MW: | 2310.6 D |
From 30.00€
*
NEW
MAIT-203 acetate
Item number: TGM-TP3070-1mg
Description: MAIT-203 acetate is a cyclopentylglycine-derived peptidomimetic that effectively inhibits the interaction between adenomatous polyposis coli (APC) and Asef (RhoGEF4), while not affecting the APC-Sam68 or APC-striatin interactions. It binds to APC-ARM with a Ki of 0.015 µM and a Kd of 0.036 µM,...
| MW: | 2517.85 D |
From 93.00€
*
NEW
Sifuvirtide acetate
Item number: TGM-TP3075-1mg
Description: Sifuvirtide (SFT) acetate is a potent inhibitor of HIV fusion. It effectively inhibits HIV-1-mediated cell fusion in a dose-dependent manner and demonstrates high efficacy against infections caused by both primary and laboratory-adapted HIV-1 isolates of various genotypes. Sifuvirtide acetate is...
| Keywords: | Sifuvirtide acetate , SFT acetate |
| MW: | 4727.98 D |
From 78.00€
*
NEW
SMR efflux inhibitor
Item number: TGM-TP3083-10mg
Description: SMR efflux inhibitor disrupts the interaction between TM4-TM4 of the small multidrug resistance (SMR) efflux pump and demonstrates broad-spectrum antibacterial activity. Target: Antibacterial
| MW: | 2040.62 D |
Please request pricing for this article.
NEW
Pegevongitide
Item number: TGM-TP3098-10mg
Description: Pegevongitide acts as an agonist of the angiopoietin-1 receptor. Target: ANGPTL
| MW: | ~14600 D |
Please request pricing for this article.
NEW
PAP 248-286 acetate
Item number: TGM-TP3112-1mg
Description: PAP 248-286 (Prostaticacid phosphatase(248-286)) acetate is a biologically active peptide. Identified in semen as a semen-derived enhancer of viral infection (SEVI) factor, this peptide significantly boosts HIV infection by facilitating the attachment of viral particles to target cells. Target: HIV...
| Keywords: | PAP 248-286 acetate , Prostatic acid phosphatase (248-286) acetate |
| MW: | 4551.39 D |
From 163.00€
*
NEW
Atrial natriuretic factor (1-28) (human, porcine) TFA
Item number: TGM-TP3116-1mg
Description: Atrial natriuretic factor (1-28) (human, porcine) TFA exhibits antihypertensive activity by promoting sodium and urine excretion. It inhibits the release of adrenocorticotropic hormone (ACTH) and beta-endorphin by suppressing pro-opiomelanocortin (POMC) expression. Additionally, it elevates cGMP levels...
| Keywords: | Atrial natriuretic factor (1-28) (human, porcine) TFA , Atrial natriuretic peptide (1-28) TFA |
| MW: | 3080.46 D |
From 118.00€
*
NEW
HPN536
Item number: TGM-TP3117-10mg
Description: HPN536 is a trispecific T-cell activating protein construct that binds to tumor cells expressing mesothelin, the CD3epsilon on T cells, and serum albumin. It specifically redirects T cells for the potent redirected lysis of cancer cells expressing mesothelin while simultaneously activating T cells....
Please request pricing for this article.
NEW
HR97 TFA
Item number: TGM-TP3118-1mg
Description: HR97 TFA is a cell-penetrating peptide that binds with engineered melanin to produce the eye drop solution HR97-SunitiGel. The peptide-drug conjugate within HR97-SunitiGel allows for sustained ocular drug delivery.
| MW: | 1518.84 D |
From 134.00€
*